Home » Chemical News » Competition in Global Voglibose Market to Grow in the Years to Come
Competition in Global Voglibose Market to Grow in the Years to Come Home
News
Market Reports
2 Jun, 2016 in Chemical News tagged Diabetes / Pharmaceuticals / Voglibose by Andrew
Custom Research
Search Report Search Cart Products… - $0.00
Login
Search About Us
Report Categories Voglibose is an alpha-glucosidase inhibitor that exhibits anti-diabetic, anti- hyperglycemic, antihyperlipidemic, anti-melanogenic, and cardioprotective benefits. It is used for lowering postprandial blood glucose levels in people with diabetes mellitus.
Coatings & Adhesives
The market of Voglibose is mainly distributed in Europe, Asia-Pacific etc, such as Japan, South Korea, Germany and China. The global market for Voglibose is expected to reach over $1.0 billion by 2021, at a CAGR of 5.7% from 2015 to 2021. The growth of the global market is driven by the rising income levels, the rising awareness regarding the medicinal benefits of Voglibose.
Organic Chemicals
Voglibose acts by inhibition of alpha-glucosidase, an enzyme involved in the breakdown of ingested disaccharides (eg sucrose, maltose) into monosaccharides (eg glucose, fructose) in the gut to facilitate their absorption. The drug is taken just before meals to prevent the postprandial hyperglycemia seen in diabetics. This type of agent can be considered a drug of first choice in overweight diabetic patients, because unlike the sulphonylureas they are not known to stimulate weight gain. Consumption of Voglibose grew dramatically during 2008-2013, mainly as the demand from Japan and China etc. Global market for Voglibose was faced strong competition from generics, retooled drugs, other diabetes drugs etc. As it approved in Japan, Korea, China, Asia Pacific dominated the global Voglibose market in terms of volume and revenue. This trend is estimated to continue throughout the forecast period. The Asia Pacific Voglibose market is closely followed by Europe.
Food & Feed Additives Oleochemicals Pesticides Pharmaceutical Ingredients Polyurethane Silicones Surfactants
Top Rated Products N-Iodosuccinimide China Market and Forecast Research $1,800.00
Growth in the diabetes drugs sectors in Asia Pacific and Europe regions is a key factor for the high demand for voglibose. The production of Voglibose is mainly distributed in Japan, India, China etc.
N-Iodosuccinimide
Key market participants include Takeda Pharmaceutical Company Limited, Taj Group, Kissei
Forecast Research
PDFmyURL - online url to pdf conversion
Global Market and